Financhill
Back

Appili Therapeutics Quote, Financials, Valuation and Earnings

Appili Therapeutics Price Quote

$0.03
+0.00 (+2.04%)
(Updated: May 4, 2024 at 6:07 AM ET)

Appili Therapeutics Key Stats

Sell
41
Appili Therapeutics (APLIF) is a Sell

Day range:
$0.02 - $0.03
52-week range:
$0.02 - $0.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
86.8K
Avg. volume:
315.8K
1-year change:
12%
Market cap:
$3.4M
Revenue:
$252.8K
EPS:
$-0.03

How Much Does Appili Therapeutics Make?

Data Unavailable

Is Appili Therapeutics Growing As A Company?

Data Unavailable

Appili Therapeutics Stock Price Performance

What Is Appili Therapeutics 52-Week High & Low?

Appili Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Appili Therapeutics?

Is Appili Therapeutics Cash Flow Positive?

  • What Is APLIF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$2.5M
  • What Is Appili Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.8M
  • What Is Appili Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$26.8K

Appili Therapeutics Return On Invested Capital

Data Unavailable

Appili Therapeutics Earnings Date & Stock Price

Appili Therapeutics Competitors

Appili Therapeutics Dividend Yield

Data Unavailable

Appili Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.15
Upside from Last Price: 435.71%

Major Shareholders

  • How many APLIF shares are owned by institutional investors?
    5.3M APLIF shares are owned by institutional investors
  • How many APLIF shares are owned by insiders?
    0 APLIF shares are owned by insiders